|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| ASSETS | ||||
| Deferred offering costs | ||||
| Current Assets | ||||
| Cash | ||||
| Cash and cash equivalents | ||||
| Prepaid expenses | ||||
| Prepaid insurance | ||||
| Total Current Assets | ||||
| Long-term prepaid insurance | ||||
| Investments held in Trust Account | ||||
| TOTAL ASSETS | ||||
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT | ||||
| Current Liabilities | ||||
| Accrued offering costs | ||||
| Promissory note – related party | ||||
| Related Party | ||||
| Total promissory note – related party | ||||
| Accrued expenses | ||||
| Over-allotment liability | ||||
| Due to sponsor | ||||
| Related Party | ||||
| Total due to sponsor | ||||
| Total Current Liabilities | ||||
| Deferred underwriting fee payable | ||||
| Total Liabilities | ||||
| Class A ordinary shares subject to possible redemption, 21,500,000 and 20,000,000 shares at a redemption value of $10.19 and $10.01 per share as of June 30, 2026 and December 31, 2025, respectively | ||||
| Shareholders’ Deficit | ||||
| Common stock, value | ||||
| Class A | ||||
| Class B Ordinary Shares | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| Total Shareholders’ Deficit | ||||
| TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT |
Loading...
